Twelve Weeks of Pioglitazone Therapy Significantly Attenuates Dysmetabolism and Reduces Inflammation in Continuous Ambulatory Peritoneal Dialysis Patients—a Randomized Crossover Trial

♦ Background: The aim of the present study was to investigate the effect of oral pioglitazone (PIO) on lipid metabolism, insulin resistance, inflammation, and adipokine metabolism in continuous ambulatory peritoneal dialysis (CAPD) patients. ♦ Methods: In this randomized crossover trial, 36 CAPD pat...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Li, Yun, Xie, Qiong-hong, You, Huai-zhou, Tian, Jing, Hao, Chuan-ming, Lin, Shan-yan, Zhu, Tong-ying
Formato: Artigo
Idioma:Inglês
Publicado em: Multimed Inc 2012
Assuntos:
Original Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3524878/
https://ncbi.nlm.nih.gov/pubmed/22383630
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3747/pdi.2011.00116
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados